Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients

被引:113
作者
Wintermeyer, P
Krüger, R
Kuhn, W
Müller, T
Woitalla, D
Berg, D
Becker, G
Leroy, E
Polymeropoulos, M
Berger, K
Przuntek, H
Schöls, L
Epplen, JT
Riess, O
机构
[1] Ruhr Univ Bochum, Dept Neurol, D-44791 Bochum, Germany
[2] Ruhr Univ Bochum, Dept Human Mol Genet, D-44791 Bochum, Germany
[3] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany
[4] Novartis Pharmaceut Corp, Pharmacogenet Dept, Gaithersburg, MD USA
[5] Univ Munster, Inst Epidemiol & Social Med, D-4400 Munster, Germany
[6] Univ Rostock, Childrens Hosp, Dept Med Genet, D-2500 Rostock 1, Germany
关键词
autosomal dominant; Parkinson's disease; population studies; UCHL1;
D O I
10.1097/00001756-200007140-00004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recently, an Ile93Met substitution has been identified in the ubiquitin carboxy-terminal hydrolase LI (UCHL1) gene in a single German PD family with autosomal dominant inheritance. To determine whether mutations in the UCHL1 gene are causative for Parkinson's disease (PD) a detailed mutation analysis was performed in a large sample of German sporadic and familial PD patients. We found no disease-causing mutation in the coding region of the UCHL1 gene. Direct sequencing revealed six intronic polymorphisms in the UCHL1 gene. Analysis of an S18Y polymorphism in exon 3 of the UCHL1 gene in sporadic PD patients and controls showed carriers of allele 2 (tyrosine) significantly less frequent in patients with a reduced risk of 0.57 (CI=0.36-0.88; p=0.012, p(c)=0.047, chi(2)=6.31). Our study shows that sequence variations in the coding region of UCHL1 are a rare event. A protective effect of a certain UCHL1 variant in the pathogenesis of sporadic PD is suggested, underlining the relevance of UCHL1 in neurodegeneration. NeuroReport 11:2079-2082 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:2079 / 2082
页数:4
相关论文
共 24 条
[1]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[2]   Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density [J].
Comings, DE .
MOLECULAR PSYCHIATRY, 1999, 4 (03) :213-215
[3]  
FAHN S, 1987, MACMILLAN HLTH CARE, P153
[4]   A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor [J].
Farrer, M ;
Gwinn-Hardy, K ;
Muenter, M ;
DeVrieze, FW ;
Crook, R ;
Perez-Tur, J ;
Lincoln, S ;
Maraganore, D ;
Adler, C ;
Newman, S ;
MacElwee, K ;
McCarthy, P ;
Miller, C ;
Waters, C ;
Hardy, J .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :81-85
[5]   The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease [J].
Harhangi, BS ;
Farrer, MJ ;
Lincoln, S ;
Bonifati, V ;
Meco, G ;
De Michele, G ;
Brice, A ;
Dürr, A ;
Martinez, M ;
Gasser, T ;
Bereznai, B ;
Vaughan, JR ;
Wood, NW ;
Hardy, J ;
Oostra, BA ;
Breteler, MMB .
NEUROSCIENCE LETTERS, 1999, 270 (01) :1-4
[6]  
Hense H W, 1993, Ann Epidemiol, V3, P410
[7]   Analysis of the Parkin deletion in sporadic and familial Parkinson's disease [J].
Krüger, R ;
Vieira-Säcker, AMM ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Schöls, L ;
Przuntek, H ;
Epplen, JT ;
Riess, O .
JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (02) :159-163
[8]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[9]  
Krüger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO
[10]  
2-X